Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Lilly OncologyLilly Oncology
VS
Teva PharmaceuticalsTeva Pharmaceuticals
Lilly Oncology

Lilly Oncology

893 S Delaware St, Indianapolis, 46225, US

Last Update: 29/12/2025

View Profile
763/1000Fair

Since 1961, Lilly has been dedicated to delivering life-changing medicines for people living with cancer. Our scientists are urgently advancing new discoveries with the goal of transforming some of the most difficult-to-treat cancers into manageable diseases. Our appro...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:21
12-month incidents
0
Known data breaches
0
Attack type number
0
Teva Pharmaceuticals

Teva Pharmaceuticals

124 Dvora hanevi'a, Tel-Aviv, IL, 6944020

Last Update: 28/03/2026

View Profile
Between 800 and 849
http://www.tevapharm.com
805/1000Good

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicin...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:29,951
Subsidiaries:5
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Lilly Oncology

Lilly Oncology

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Teva Pharmaceuticals

Teva Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Lilly Oncology in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Teva Pharmaceuticals in 2026.

Incidents

Incident History - Lilly Oncology (X = Date, Y = Severity)

Lilly Oncology cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Teva Pharmaceuticals (X = Date, Y = Severity)

Teva Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Lilly Oncology

Lilly Oncology

Incidents
No explicit notable incidents reported.
Teva Pharmaceuticals

Teva Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between Lilly Oncology company and Teva Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between Lilly Oncology company and Teva Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between Lilly Oncology company and Teva Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between Lilly Oncology company and Teva Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between Lilly Oncology company and Teva Pharmaceuticals company, which one has experienced at least one data breach ?
Between Lilly Oncology company and Teva Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between Lilly Oncology company and Teva Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between Lilly Oncology company and Teva Pharmaceuticals company, which one holds the most compliance certifications ?
Between Lilly Oncology company and Teva Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between Lilly Oncology company and Teva Pharmaceuticals company, which one has the most subsidiaries ?
Between Lilly Oncology company and Teva Pharmaceuticals company, which one has the largest number of employees ?
Between Lilly Oncology and Teva Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between Lilly Oncology and Teva Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Lilly Oncology or Teva Pharmaceuticals ?
Which company is PCI DSS compliant - Lilly Oncology or Teva Pharmaceuticals ?
Between Lilly Oncology and Teva Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between Lilly Oncology and Teva Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-13512
SUMMARY

A vulnerability was identified in Databend up to 1.2.881 on HTTP. This affects the function ClientSessionManager::state_key of the file src/query/service/src/servers/http/v1/session/client_session_manager.rs of the component Tenant Handler. The manipulation leads to authorization bypass. It is possible to initiate the attack remotely. The exploit is publicly available and might be used. The pull request to fix this issue awaits acceptance.

PUBLISHED
Date2026-06-28
UPDATED
Date2026-06-28
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-13511
SUMMARY

A vulnerability was determined in VoltAgent up to 2.1.17. Affected by this issue is the function handleGetMemoryConversation of the file packages/server-core/src/handlers/memory.handlers.ts of the component Memory REST API. Executing a manipulation of the argument conversationId can lead to improper authorization. The attack may be performed from remote. This attack is characterized by high complexity. The exploitation is known to be difficult. The exploit has been publicly disclosed and may be utilized. The pull request to fix this issue awaits acceptance.

PUBLISHED
Date2026-06-28
UPDATED
Date2026-06-28
RISK INFORMATION (Score: 3.1)
CVSS2
Base Score: 2.1
Complexity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
CVSS3
Base Score: 3.1
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 1.3
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
1.6
CVE-2026-13510
SUMMARY

A vulnerability was found in SimStudioAI sim up to 0.6.92. Affected by this vulnerability is an unknown functionality in the library apps/sim/lib/core/security/deployment.ts of the component Password Protection Handler. Performing a manipulation results in use of weak hash. The attack is possible to be carried out remotely. The attack's complexity is rated as high. The exploitation appears to be difficult. The exploit has been made public and could be used. The pull request to fix this issue awaits acceptance.

PUBLISHED
Date2026-06-28
UPDATED
Date2026-06-28
RISK INFORMATION (Score: 3.7)
CVSS2
Base Score: 2.6
Complexity: HIGH
AV:N/AC:H/Au:N/C:P/I:N/A:N
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 2.9
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-13509
SUMMARY

A vulnerability has been found in RAGapp up to 0.1.5. Affected is the function FileHandler.upload_file/FileHandler.remove_file of the file src/ragapp/backend/controllers/files.py of the component Knowledge File Handler. Such manipulation leads to path traversal. The attack can be executed remotely. The exploit has been disclosed to the public and may be used. The pull request to fix this issue awaits acceptance.

PUBLISHED
Date2026-06-28
UPDATED
Date2026-06-28
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-13508
SUMMARY

A flaw has been found in khoj-ai khoj up to 2.0.0-beta.28. This impacts an unknown function of the file src/khoj/routers/api_chat.py of the component Conversation Sharing Handler. This manipulation of the argument conversation.agent causes incorrect authorization. Remote exploitation of the attack is possible. The exploit has been published and may be used. The pull request to fix this issue awaits acceptance.

PUBLISHED
Date2026-06-28
UPDATED
Date2026-06-28
RISK INFORMATION (Score: 5.5)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.1